Expression and function of striatal nAChRs differ in the Flinders sensitive (FSL) and resistant (FRL) rat lines

被引:13
作者
Auta, J
Lecca, D
Nelson, M
Guidotti, A
Overstreet, DH
Costa, E
Javaid, JI
机构
[1] Univ Illinois, Coll Med, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA
[2] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
关键词
Flinders lines rats; nicotine; mecamylamine; nicotinic acetylcholine; receptors; in vivo microdialysis; dopamine;
D O I
10.1016/S0028-3908(00)00082-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rats of Flinders Sensitive (FSL) and Flinders Resistant lines (FRL) differ in their susceptibility to physiological and associated behavioral responses elicited by nicotine. In the present study, we measured dopamine (DA) content in striatal dialysates to investigate the sensitivity of FSL and FRL rats to nicotine delivered locally through a microdialysis probe placed in the striatum. We also measured the expression density of striatal high-affinity nicotinic acetylcholine receptors (nAChRs), and that of mRNAs encoding for alpha3, alpha4, alpha7 and beta2 nAChR subunits in both lines. The DA content of dialysates was measured before and after a 1-min perfusion of nicotine (6, 10 or 20 nmoles/min) and the resulting DA increase was taken as a measure of the alkaloid's intrinsic activity for nAChRs involved in the release of DA. The nicotine-induced increase of striatal DA release was greater in FSL than in FRL rats for all concentrations of nicotine, suggesting that the intrinsic activity of nicotine was greater in the FSL than in the FRL rats. This was further supported by our finding that the density of high-affinity nAChRs in the striatum of FSL rats was 44% greater than in the FRL rats, whereas affinity (K-D) was virtually the same in the two lines of rats. Also the expression of mRNAs encoding for alpha (4), alpha (7), and beta (2) subunits in the striatum was greater in FSL than in FRL rats (attomol/mug total RNA, alpha (4):98+/-10 vs 77+/-7; alpha (7):279+/-16 vs 184+/-16; beta (2):310+/-19 vs 201+/-12). We hypothesize that the difference in nicotine-induced DA release in the striatum of FSL and FRL rats depends on the difference in nAChR subunit expression in the striatum between the two lines. The Flinders rats could be used as a model for nicotine self-administration studies to evaluate the susceptibilities of FSL and FRL rats to nicotine dependence. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2624 / 2631
页数:8
相关论文
共 32 条
[1]   The regulation of hippocampal nicotinic acetylcholine receptors (nAChRs) after a protracted treatment with selective or nonselective nAChR agonists [J].
Auta, J ;
Longone, P ;
Guidotti, A ;
Costa, E .
JOURNAL OF MOLECULAR NEUROSCIENCE, 1999, 13 (1-2) :31-45
[2]   ALPHA-BUNGAROTOXIN BINDING-SITES IN RAT HIPPOCAMPAL AND CORTICAL CULTURES - INITIAL CHARACTERIZATION, COLOCALIZATION WITH ALPHA-7 SUBUNITS AND UP-REGULATION BY CHRONIC NICOTINE TREATMENT [J].
BARRANTES, GE ;
ROGERS, AT ;
LINDSTROM, J ;
WONNACOTT, S .
BRAIN RESEARCH, 1995, 672 (1-2) :228-236
[3]   DISTINCT DEVELOPMENTAL PATTERNS OF EXPRESSION OF RAT ALPHA, ALPHA-5, GAMMA-2S, AND GAMMA-2L GAMMA-AMINOBUTYRIC ACIDA RECEPTOR SUBUNIT MESSENGER-RNAS INVIVO AND INVITRO [J].
BOVOLIN, P ;
SANTI, MR ;
MEMO, M ;
COSTA, E ;
GRAYSON, DR .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (01) :62-72
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
Brioni J D, 1997, Adv Pharmacol, V37, P153
[6]  
CARUNCHO HJ, 1994, RECEPTOR CHANNEL, V2, P143
[7]  
FLORES CM, 1992, MOL PHARMACOL, V41, P31
[8]  
GALLO V, 1992, J NEUROSCI, V12, P1010
[9]   NICOTINE AND SOME RELATED-COMPOUNDS - EFFECTS ON SCHEDULE-CONTROLLED BEHAVIOR AND DISCRIMINATIVE PROPERTIES IN RATS [J].
GOLDBERG, SR ;
RISNER, ME ;
STOLERMAN, IP ;
REAVILL, C ;
GARCHA, HS .
PSYCHOPHARMACOLOGY, 1989, 97 (03) :295-302
[10]   CHARACTERIZATION OF NICOTINIC RECEPTOR-MEDIATED [H-3] DOPAMINE RELEASE FROM SYNAPTOSOMES PREPARED FROM MOUSE STRIATUM [J].
GRADY, S ;
MARKS, MJ ;
WONNACOTT, S ;
COLLINS, AC .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) :848-856